Sonoma Pharmaceuticals (SNOA) EBT Margin (2010 - 2026)
Sonoma Pharmaceuticals' (SNOA) quarterly EBT Margin came in at 8.94% in Q1 2026, up 513.0% year-on-year from 1.46% in Q1 2025, and up 59.04% quarter-over-quarter from 21.82% in Q4 2025.
Sonoma Pharmaceuticals (SNOA) EBT Margin (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' EBT Margin history runs 17 years deep, the most recent figure standing at 8.94% for Q1 2026.
- On a quarterly basis, EBT Margin rose 513.0% year-over-year to 8.94% in Q1 2026; TTM through Mar 2026 was 17.51%, a 284.0% increase from a year earlier, with the FY2026 full-year figure at 17.51%, up 284.0% from the prior year.
- EBT Margin climbed to 8.94% in Q1 2026 per SNOA's latest filing, from 21.82% in the prior quarter.
- Across five years, EBT Margin topped out at 8.94% in Q1 2026 and bottomed at 142.82% in Q1 2022.
- The 5-year median for EBT Margin is 29.4% (2024), against an average of 36.57%.
- Across the five-year window, EBT Margin tumbled 3218 bps in 2022 and jumped 9508 bps in 2023, its largest moves.
- Year by year, EBT Margin stood at 64.71% in 2022, then soared by 55 bps to 29.41% in 2023, then gained by 12 bps to 25.79% in 2024, then climbed by 15 bps to 21.82% in 2025, then surged by 59 bps to 8.94% in 2026.
- Per Business Quant, the three latest SNOA EBT Margin figures stand at 8.94% (Q1 2026), 21.82% (Q4 2025), and 13.04% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 10.97% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 33.51% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -41.57% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.73% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -7.05% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 30.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.35% |
| 10 | Sonoma Pharmaceuticals | 179.80 | -2.40 Mn | 2.18 Mn | -8.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.94% |
| Dec 31, 2025 | -21.82% |
| Sep 30, 2025 | -13.04% |
| Jun 30, 2025 | -30.93% |
| Mar 31, 2025 | -14.06% |
| Dec 31, 2024 | -25.79% |
| Sep 30, 2024 | -12.94% |
| Jun 30, 2024 | -29.40% |
| Mar 31, 2024 | -39.52% |
| Dec 31, 2023 | -29.41% |
| Sep 30, 2023 | -47.53% |
| Jun 30, 2023 | -42.34% |
| Mar 31, 2023 | -47.74% |
| Dec 31, 2022 | -64.71% |
| Sep 30, 2022 | -27.53% |
| Jun 30, 2022 | -23.15% |
| Mar 31, 2022 | -142.82% |
| Dec 31, 2021 | -32.53% |
| Sep 30, 2021 | -2.54% |
| Jun 30, 2021 | -29.80% |